— Know what they know.
Not Investment Advice

AUTL NASDAQ

Autolus Therapeutics plc
1W: -4.3% 1M: -20.5% 3M: +9.2% YTD: -4.8% 1Y: +6.6% 3Y: -23.3% 5Y: -71.7%
$1.78
-0.07 (-3.78%)
 
Weekly Expected Move ±6.9%
$2 $2 $2 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 32 · $473.7M mcap · 241M float · 0.753% daily turnover · Short 51% of daily vol

📊 Key Metrics

TTM
$117M
Revenue
+292.0% YoY
$-280M
Net Income
-22.9% YoY
$-237M
Free Cash Flow
+23.9% YoY
55.2%
Gross Margin
-95.9%
Op. Margin
-85.6%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-132.9%
ROA-46.1%
ROIC451.5%

Valuation

P/E-1.7
P/B6.3
EV/EBITDA-1.4

Leverage

Debt/Equity1.12
Current Ratio4.89
Interest Cov.-4.9x

Quality Scores

Piotroski F3/9
Altman Z-4.31
Beneish M-3.19

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms